Trials / Completed
CompletedNCT02111733
Is High Sensibility Troponins a Dialysable Marker in Hemodialysis Patients and Does it Have Prognostic Value?
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 43 (actual)
- Sponsor
- Université de Sherbrooke · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of High sensibility troponin levels modification by hemodialysis in terminal renal failure patient at Sherbrooke University Hospital Center as determined by serial measurements. Verification of potential effects of these levels and their variation as predictors of cardiovascular outcomes and events at 6 and 12 months.
Detailed description
Recruiting of hemodialysis patients of the nephrology renal supplementation clinics at Sherbrooke University Hospital Center to measure three blood level of high-sensibility troponins before and after standard dialysis. Verification on the variation of these levels after dialysis. Follow-up at 6 and 12 months of the patient for Cardiovascular events and death and verification of a possible predictive value of troponin blood levels for these events.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Hs-TNT dosage | Bloodwork before and after hemodialysis for high sensibility troponins T blood level |
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2013-09-01
- Completion
- 2013-09-01
- First posted
- 2014-04-11
- Last updated
- 2014-04-11
Locations
2 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT02111733. Inclusion in this directory is not an endorsement.